Scott Davie BSc

Scott Davie joined its executive leadership team as Chief Technology Officer. Davie will be responsible for leading Alio’s technical teams in developing the Alio platform and SmartPatch wearable technology.

Davie’s deep and diverse set of experiences lends itself to the evolution and future applications of Alio’s technology. Davie has more than 25 years of medical device experience in relevant disease states and applications. His expertise in the management of various chronic conditions positions him to effectively manage the Alio platform to reach its full potential in remote dialysis patient monitoring.

Davie comes to Alio from TriSalus Life Sciences, a company focused on treating patients with solid tumors. Davie served as Chief Technology Officer at TriSalus, where he oversaw research and development of the company’s intravascular infusion systems, technical operations, pre-clinical execution, and IP portfolio management.

Previously Davie held several technical leadership positions at Medtronic. Throughout his nearly twenty-year tenure, he delivered a number of complex therapeutic and diagnostic systems from conceptualization through market launch. These systems included implantable cardiac devices, AF ablation systems, and hospital-based diagnostic platforms. He acquired a broad range of quality, regulatory, and clinical experience as well.